Advertisement

Topics

French Biotech Develops a New Generation of Safer CAR-T Cells

12:47 EDT 13 Jun 2018 | Labiotech.eu

Cellectis is developing a new type of chimeric antigen receptor that could improve the production and safety of CAR-T cell therapies generated from both patient and donor cells. Cellectis, a French biotech focused on developing CAR-T therapies from donor cells, ...

The post French Biotech Develops a New Generation of Safer CAR-T Cells appeared first on Labiotech.eu.

Original Article: French Biotech Develops a New Generation of Safer CAR-T Cells

NEXT ARTICLE

More From BioPortfolio on "French Biotech Develops a New Generation of Safer CAR-T Cells"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...